Remission of transformed myelodysplastic syndrome with fibrosis after danazol therapy.
Danazol has been used with success in some hematological diseases, but there is no report of this treatment in acute leukemia. We report here a case of remission of myelodysplastic syndrome with myelofibrosis in transformation after danazol therapy in a 72-yr-old man. The role of danazol in remission induction is briefly discussed.
Damaj
G
G
Department of Clinical Hematology, Hôpital Necker Enfants-Malades, Paris, France. damajg@marseille.fnclcc.fr
Lefrère
F
F
Canioni
D
D
Rubio
M T
MT
Radford-Weiss
I
I
Valensi
F
F
Varet
B
B
Hermine
O
O
D000368:Aged; D003613:Danazol / Q000627:therapeutic use*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000473:pathology*; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D012074:Remission Induction
D004965:Estrogen Antagonists; D003613:Danazol